Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | APEX1 | P27695 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | RAD52 | P43351 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9131789 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL9131805 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL5702900 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL9132044 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL28319571 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL22325602 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL24205467 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL9133801 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL9136941 | 0.98 | TSHR (0.67) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL3413686 | 0.98 | TSHR (0.66) | TSHRPOLBAPEX1HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117466819-A | Imidazole ionic liquid, preparation method thereof, bio-based photo-curing coating and application | 苏州科技大学 | 2024-01-30 | — | — | CN | claimed |
| JP-8113763-A | — | — | None | — | — | JP | disclosed |
| CN-117466819-A | Imidazole ionic liquid, preparation method thereof, bio-based photo-curing coating and application | 苏州科技大学 | 2024-01-30 | — | — | CN | disclosed |
| CN-117466819-A | Imidazole ionic liquid, preparation method thereof, bio-based photo-curing coating and application | 苏州科技大学 | 2024-01-30 | — | — | CN | disclosed |
| US-20230273456-A1 | OPTICALLY ACTIVE DEVICES | JOHNSON & JOHNSON SURGICAL VISION INC (US) | 2023-08-31 | — | — | US | disclosed |
| US-20230273455-A1 | OPTICALLY ACTIVE DEVICES | JOHNSON & JOHNSON SURGICAL VISION INC (US) | 2023-08-31 | — | — | US | disclosed |
| US-20230273455-A1 | OPTICALLY ACTIVE DEVICES | JOHNSON & JOHNSON SURGICAL VISION INC (US) | 2023-08-31 | — | — | US | disclosed |
| EP-2969917-B1 | POLYMERIZED IONIC LIQUID BLOCK COPOLYMERS AS BATTERY MEMBRANES | UNIV DREXEL (US) | 2022-11-02 | — | — | EP | disclosed |
| US-20200339512-A1 | POLYMERIZABLE COMPOUNDS WITH ONE OR MORE SURFACTANT-LIKE PROPERTIES | EXIGENCE TECHNOLOGIES INC. (CA) | 2020-10-29 | — | — | US | disclosed |
| CN-104981426-B | The ionic liquid block copolymer of polymerization as battery membranes | 德雷塞尔大学 | 2019-09-17 | — | — | CN | disclosed |
| EP-1070731-A1 | Compound | Rolic AG (CH) | 2001-01-24 | — | — | EP | disclosed |
| WO-2000059966-A1 | PHOTOACTIVE POLYMERS | ROLIC AG (CH) | 2000-10-12 | — | — | WO | disclosed |
| JP-H08113763-A | SURFACE-TREATING AGENT FOR ADHESION | TOKUYAMA CORP | 1996-05-07 | — | — | JP | disclosed |
| US-5441731-A | A ion exchange resin based on a cationic polymer of an alkyl alkacrylate, a oligoyalkylene glycol dimethacrylate acid and a trialkylammonioalkyl methacrylate; antichloesterol agent | SMITHKLINE & FRENCH LABORATORIES LTD. (GB) | 1995-08-15 | — | — | US | disclosed |
| EP-0373852-B1 | Compounds | SMITH KLINE FRENCH LAB (GB) | 1994-10-26 | — | — | EP | disclosed |
| EP-0530242-A1 | COMPOUNDS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1993-03-10 | — | — | EP | disclosed |
| EP-0505406-A1 | PROCESS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1992-09-30 | — | — | EP | disclosed |
| WO-1991018027-A2 | COMPOUNDS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1991-11-28 | — | — | WO | disclosed |
| WO-1991009005-A1 | PROCESS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1991-06-27 | — | — | WO | disclosed |
| EP-0373852-A2 | Compounds | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1990-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230273456-A1 | OPTICALLY ACTIVE DEVICES | PDE6C, PDE6D, PDE6A | TSHR 4585/4885POLB 1579/4885APEX1 147/4885 |
| US-20230273455-A1 | OPTICALLY ACTIVE DEVICES | PDE6C, PDE6A, PDE6D | TSHR 4592/4885POLB 1376/4885APEX1 133/4885 |
| US-20200339512-A1 | POLYMERIZABLE COMPOUNDS WITH ONE OR MORE SURFACTANT-LIKE PROPERTIES | SMPD1, SGMS1, SMPD4 | TSHR 4787/4885POLB 1369/4885APEX1 1631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.